Department of Medicine and Clinical Science, Graduate School of Medical Sciences Kyushu University Fukuoka Japan.
Fukuoka Renal Clinic Fukuoka Japan.
J Am Heart Assoc. 2024 Aug 6;13(15):e033853. doi: 10.1161/JAHA.123.033853. Epub 2024 Aug 5.
Lower extremity peripheral arterial disease is a potentially lethal cardiovascular complication in patients undergoing hemodialysis. Anemia is a risk factor for cardiovascular disease among the hemodialysis population. However, whether blood hemoglobin concentration is associated with the risk of peripheral arterial disease progression in this population remains undetermined.
This is an extension of a 4-year multicenter, prospective, observational cohort study to 10 years. A total of 3504 Japanese patients undergoing maintenance hemodialysis were recruited between 2006 and 2007. The primary exposure was blood hemoglobin concentration at baseline. The main outcome was the first-ever incidence of major adverse limb events (MALE), composed of endovascular treatment, bypass surgery, and amputation. Multivariable-adjusted Cox proportional hazards model, Fine-Gray subdistribution hazards model, restricted cubic spline analysis, and restricted mean survival time analysis were used to determine the association of blood hemoglobin concentration with the incidence of MALE. During a median follow-up of 8.0 years, 257 patients experienced MALE. A Cox proportional hazards model showed that the risk of MALE in patients with blood hemoglobin concentrations <10.0 g/dL was significantly higher than in patients with concentrations of 11.0 to 11.9 g/dL, even after adjusting for confounding factors. In contrast, elevated hemoglobin concentration (≥12.0 g/dL) was not significantly associated with increased risk of MALE. Similar associations were observed when the Fine-Gray subdistribution regression model was used by setting all-cause mortality as the competing risk.
A low blood hemoglobin concentration is an independent risk factor for peripheral arterial disease progression in patients undergoing maintenance hemodialysis.
下肢外周动脉疾病是血液透析患者潜在致命的心血管并发症。贫血是血液透析人群心血管疾病的一个危险因素。然而,在该人群中,血液血红蛋白浓度是否与外周动脉疾病进展的风险相关仍未确定。
这是一项为期 4 年的多中心、前瞻性、观察性队列研究的扩展,随访时间延长至 10 年。共有 3504 名接受维持性血液透析的日本患者于 2006 年至 2007 年期间入组。主要暴露因素为基线时的血液血红蛋白浓度。主要结局为首次主要不良肢体事件(MALE)的发生,包括血管内治疗、旁路手术和截肢。多变量调整的 Cox 比例风险模型、Fine-Gray 亚分布风险模型、限制立方样条分析和限制平均生存时间分析用于确定血液血红蛋白浓度与 MALE 发生率的关系。在中位数为 8.0 年的随访期间,257 名患者发生了 MALE。Cox 比例风险模型显示,血红蛋白浓度<10.0 g/dL 的患者发生 MALE 的风险明显高于浓度为 11.0 至 11.9 g/dL 的患者,即使在调整了混杂因素后也是如此。相比之下,血红蛋白浓度升高(≥12.0 g/dL)与 MALE 风险增加无显著相关性。当将全因死亡率设为竞争风险并使用 Fine-Gray 亚分布回归模型时,也观察到了类似的关联。
低血液血红蛋白浓度是维持性血液透析患者外周动脉疾病进展的独立危险因素。